BSX vs MEDP · P/E 20, rev $10.65B vs P/E 25, rev $707.3M
Boston Scientific Corp (BSX) versus Medpace Holdings Inc (MEDP) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Not investment advice. Open the BSX and MEDP stock pages for the full models.
Not investment advice.